ID   Hs 573.T
AC   CVCL_0804
SY   HS 573T; Hs573.T; Hs573T; 573
DR   CLO; CLO_0004005
DR   ATCC; CRL-7343
DR   BioSample; SAMN03471573
DR   cancercelllines; CVCL_0804
DR   GEO; GSM827559
DR   Progenetix; CVCL_0804
DR   Wikidata; Q54895768
RX   PubMed=6500159;
RX   PubMed=7171457;
RX   PubMed=20215515;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-7343; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-7343
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0803 ! Hs 573.Lu
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
RX   PubMed=6500159; DOI=10.1159/000163283;
RA   Gershwin M.E., Lentz D., Owens R.B.;
RT   "Relationship between karyotype of tissue culture lines and
RT   tumorigenicity in nude mice.";
RL   Exp. Cell Biol. 52:361-370(1984).
//
RX   PubMed=7171457; DOI=10.1038/bjc.1982.272; PMCID=PMC2011156;
RA   Brown D.T., Moore M.;
RT   "Monoclonal antibodies against two human lung carcinoma cell lines.";
RL   Br. J. Cancer 46:794-801(1982).
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662;
RA   Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P.,
RA   Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J.,
RA   Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C.,
RA   Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J.,
RA   Haber D.A.;
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//